Trademark Overview
On Tuesday, January 9, 2018, a trademark application was filed for RXULTI with the United States Patent and Trademark Office. The USPTO has given the RXULTI trademark a serial number of 87748334. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, July 31, 2018. This trademark is owned by H. Lundbeck A/S. The RXULTI trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndr...
